Article Type
Article
Changed
Tue, 05/03/2022 - 16:03
Display Headline
The Niacin Debate Continues: Higher Doses, Please
Author(s)
Felicetta JV

Article PDF
026070012.pdf
Author and Disclosure Information

James V. Felicetta, MD

Issue
Federal Practitioner - 26(7)
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Cardiology
Diabetes
Page Number
12
Legacy Keywords
niacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterolniacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterol
Sections
Commentary
Author(s)
Felicetta JV
Author(s)
Felicetta JV
Author and Disclosure Information

James V. Felicetta, MD

Author and Disclosure Information

James V. Felicetta, MD

Article PDF
026070012.pdf
Article PDF
026070012.pdf

Issue
Federal Practitioner - 26(7)
Issue
Federal Practitioner - 26(7)
Page Number
12
Page Number
12
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Cardiology
Diabetes
Article Type
Article
Display Headline
The Niacin Debate Continues: Higher Doses, Please
Display Headline
The Niacin Debate Continues: Higher Doses, Please
Legacy Keywords
niacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterolniacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterol
Legacy Keywords
niacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterolniacin, lipoprotein, diabetes, glycemic, lipid, LDL, statins, adverse effects, drug effects, flushing, pruritus, cholesterol
Sections
Commentary
Article Source

PURLs Copyright

Inside the Article

Article PDF Media